Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Share-based Compensation (2016 - 2018)

Historic Share-based Compensation for Fresenius Medical Care AG (FMS) over the last 9 years, with Q4 2018 value amounting to $4259.7.

  • Fresenius Medical Care AG's Share-based Compensation fell 7863.47% to $4259.7 in Q4 2018 from the same period last year, while for Dec 2018 it was $4259.7, marking a year-over-year decrease of 7863.47%. This contributed to the annual value of $177000.0 for FY2019, which is 9880.15% down from last year.
  • Per Fresenius Medical Care AG's latest filing, its Share-based Compensation stood at $4259.7 for Q4 2018, which was down 7863.47% from $19937.5 recorded in Q4 2017.
  • In the past 5 years, Fresenius Medical Care AG's Share-based Compensation registered a high of $18.1 million during Q3 2016, and its lowest value of -$7.6 million during Q2 2014.
  • Its 5-year average for Share-based Compensation is $3.6 million, with a median of $4.7 million in 2014.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Share-based Compensation crashed by 21555.59% in 2014, and later skyrocketed by 115193.93% in 2016.
  • Over the past 5 years, Fresenius Medical Care AG's Share-based Compensation (Quarter) stood at $4.7 million in 2014, then surged by 36.53% to $6.4 million in 2015, then crashed by 113.49% to -$866000.0 in 2016, then soared by 102.3% to $19937.5 in 2017, then tumbled by 78.63% to $4259.7 in 2018.
  • Its Share-based Compensation was $4259.7 in Q4 2018, compared to $19937.5 in Q4 2017 and -$866000.0 in Q4 2016.